Inventor · disambiguated record
Jean-Marie Stutzmann
Also filed as: STUTZMANN JEAN-MARIE
14 granted patents·7 pending applications·190 citations·filing 1993–2011
91Inventor score
Files withAVENTIS PHARMA SA6RHONE POULENC RORER SA6AVENTIS PHARM SA1AVENTIS PHARMA1AVENTIS PHARMA INC1
Top patents by PatentIndex Score
21 records- 0185US6617316B1Oligosaccharides, their preparation and pharmaceutical compositions containing themAVENTIS PHARMA·Filed 2000·Granted Sep 9, 2003·35 cites·35 claims
- 0285US5830907AApplication of riluzole in the treatment of neurological lesions associated with traumaRHONE POULENC RORER SA·Filed 1993·Granted Nov 3, 1998·60 cites·6 claims
- 0376US6432992B1Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophyAVENTIS PHARM SA·Filed 2001·Granted Aug 13, 2002·11 cites·19 claims
- 0476US5658900AApplication of carbamazepine and oxcarbazepine in the treatment of Parkinson's disease and parkinsonian syndromesRHONE POULENC RORER SA·Filed 1994·Granted Aug 19, 1997·36 cites·2 claims
- 0575US6297254B1Method for the prevention or treatment of a motoneuron diseaseAVENTIS PHARMA SA·Filed 2000·Granted Oct 2, 2001·5 cites·11 claims
- 0668US5502049AUse of phenothiazine derivatives in the treatment of ischaemia and/or hypoxiaRHONE POULENC RORER SA·Filed 1993·Granted Mar 26, 1996·24 cites·2 claims
- 0757US2006100175A1Novel therapeutic use of low molecular weight heparinsAVENTIS PHARMA SA·Filed 2005·Application pending·0 cites
- 0856US2004214796A1Novel therapeutic application of enoxaparinAVENTIS PHARMA SA·Filed 2004·Application pending·0 cites
- 0955US5674885AApplication of riluzole in the treatment of parkinson's disease and parkinsonian syndromesRHONE POULENC RORER SA·Filed 1994·Granted Oct 7, 1997·11 cites·2 claims
- 1054US2003236222A1Novel therapeutic use of low molecular weight heparinsAVENTIS PHARMA SA·Filed 2003·Application pending·0 cites
- 1154US2004038938A1Novel therapeutic use of low molecular weight heparinsAVENTIS PHARMA SA·Filed 2003·Application pending·0 cites
- 1249US2002040013A1Novel therapeutic use of low molecular weight heparinsFiled 2001·Application pending·0 cites
- 1346US8431119B2Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseasesMALLET JACQUES·Filed 2007·Granted Apr 30, 2013·0 cites·2 claims
- 1445US7273854B1Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative disordersSANOFI AVENTIS·Filed 2000·Granted Sep 25, 2007·0 cites·4 claims
- 1545US2001041686A1Novel therapeutic application of enoxaparinFiled 2001·Application pending·0 cites
- 1644US6660757B2Use of riluzole in the treating acoustic traumasAVENTIS PHARMA INC·Filed 2001·Granted Dec 9, 2003·0 cites·10 claims
- 1742US6380173B1Use of low-molecular-weight heparins for the prevention and treatment of trauma of the central nervous systemAVENTIS PHARMA SA·Filed 1999·Granted Apr 30, 2002·5 cites·12 claims
- 1840US8852878B2Method for identifying an antagonist of guanine nucleotide releasing factor 1ITIER JEAN-MICHEL·Filed 2011·Granted Oct 7, 2014·0 cites·12 claims
- 1933US2005100972A1Use of grf1 protein for screening moleculesFiled 2001·Application pending·0 cites
- 2031US5686475AApplication of riluzole in the treatment of mitochondrial diseasesRHONE POULENC RORER SA·Filed 1995·Granted Nov 11, 1997·3 cites·4 claims
- 2128US5656647AApplication of riluzole for promoting restoration following radiationRHONE POULENC RORER SA·Filed 1994·Granted Aug 12, 1997·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Jean-Marie Stutzmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →